

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | pyrimidine-containing compound transmembrane transport (GO:0072531) | 8.19784345 |
| 2 | lactation (GO:0007595) | 6.78721679 |
| 3 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 6.14729577 |
| 4 | long-chain fatty-acyl-CoA biosynthetic process (GO:0035338) | 5.94210539 |
| 5 | fatty-acyl-CoA biosynthetic process (GO:0046949) | 5.91239020 |
| 6 | secretion by tissue (GO:0032941) | 5.91231370 |
| 7 | thioester biosynthetic process (GO:0035384) | 5.67908414 |
| 8 | acyl-CoA biosynthetic process (GO:0071616) | 5.67908414 |
| 9 | nucleoside transmembrane transport (GO:1901642) | 5.58682991 |
| 10 | segment specification (GO:0007379) | 5.53124207 |
| 11 | regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547) | 5.45940976 |
| 12 | linoleic acid metabolic process (GO:0043651) | 5.40411746 |
| 13 | body fluid secretion (GO:0007589) | 4.98930372 |
| 14 | positive regulation of p38MAPK cascade (GO:1900745) | 4.87574255 |
| 15 | copper ion transport (GO:0006825) | 4.81488415 |
| 16 | regulation of sequestering of triglyceride (GO:0010889) | 4.79069566 |
| 17 | regulation of apoptotic process involved in morphogenesis (GO:1902337) | 4.78594195 |
| 18 | regulation of clathrin-mediated endocytosis (GO:2000369) | 4.68518049 |
| 19 | intestinal cholesterol absorption (GO:0030299) | 4.56387187 |
| 20 | long-chain fatty-acyl-CoA metabolic process (GO:0035336) | 4.49096589 |
| 21 | prostate gland growth (GO:0060736) | 4.33208019 |
| 22 | biotin metabolic process (GO:0006768) | 4.32148540 |
| 23 | glutathione biosynthetic process (GO:0006750) | 4.28352147 |
| 24 | tooth mineralization (GO:0034505) | 4.27015961 |
| 25 | O-glycan processing (GO:0016266) | 4.26957668 |
| 26 | nucleoside transport (GO:0015858) | 4.23301822 |
| 27 | negative regulation of keratinocyte proliferation (GO:0010839) | 4.18189102 |
| 28 | nonribosomal peptide biosynthetic process (GO:0019184) | 4.14292770 |
| 29 | growth hormone receptor signaling pathway (GO:0060396) | 4.11881697 |
| 30 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 4.11515328 |
| 31 | N-acetylneuraminate metabolic process (GO:0006054) | 4.03290685 |
| 32 | type B pancreatic cell proliferation (GO:0044342) | 4.02439833 |
| 33 | mammary gland development (GO:0030879) | 4.00762226 |
| 34 | Golgi transport vesicle coating (GO:0048200) | 3.99774571 |
| 35 | COPI coating of Golgi vesicle (GO:0048205) | 3.99774571 |
| 36 | fatty-acyl-CoA metabolic process (GO:0035337) | 3.97924905 |
| 37 | regulation of penile erection (GO:0060405) | 3.96776395 |
| 38 | embryonic process involved in female pregnancy (GO:0060136) | 3.96373844 |
| 39 | peristalsis (GO:0030432) | 3.92524362 |
| 40 | branched-chain amino acid catabolic process (GO:0009083) | 3.92181086 |
| 41 | keratinocyte development (GO:0003334) | 3.87534355 |
| 42 | alpha-linolenic acid metabolic process (GO:0036109) | 3.86783164 |
| 43 | detection of chemical stimulus involved in sensory perception of taste (GO:0050912) | 3.83379696 |
| 44 | oligosaccharide metabolic process (GO:0009311) | 3.83250990 |
| 45 | regulation of phospholipid biosynthetic process (GO:0071071) | 3.75984183 |
| 46 | negative regulation of execution phase of apoptosis (GO:1900118) | 3.74781065 |
| 47 | regulation of hippo signaling (GO:0035330) | 3.72364447 |
| 48 | branched-chain amino acid metabolic process (GO:0009081) | 3.71271666 |
| 49 | surfactant homeostasis (GO:0043129) | 3.69801908 |
| 50 | lipid storage (GO:0019915) | 3.65024205 |
| 51 | short-chain fatty acid metabolic process (GO:0046459) | 3.62750279 |
| 52 | folic acid transport (GO:0015884) | 3.61856489 |
| 53 | iron ion import (GO:0097286) | 3.61227725 |
| 54 | chemical homeostasis within a tissue (GO:0048875) | 3.58686476 |
| 55 | proximal/distal pattern formation (GO:0009954) | 3.57645388 |
| 56 | positive regulation of transcription from RNA polymerase II promoter in response to stress (GO:00360 | 3.57205945 |
| 57 | intestinal epithelial cell development (GO:0060576) | 3.56296235 |
| 58 | * mammary gland epithelial cell differentiation (GO:0060644) | 3.53585756 |
| 59 | phagocytosis, recognition (GO:0006910) | 3.52898574 |
| 60 | negative regulation of protein kinase B signaling (GO:0051898) | 3.52815091 |
| 61 | regulation of vasculogenesis (GO:2001212) | 3.50252185 |
| 62 | galactose metabolic process (GO:0006012) | 3.47351296 |
| 63 | positive regulation of lipid storage (GO:0010884) | 3.45809072 |
| 64 | urinary tract smooth muscle contraction (GO:0014848) | 3.44434989 |
| 65 | cellular response to growth hormone stimulus (GO:0071378) | 3.43396294 |
| 66 | hemidesmosome assembly (GO:0031581) | 3.40805715 |
| 67 | sterol catabolic process (GO:0016127) | 3.37973118 |
| 68 | cholesterol catabolic process (GO:0006707) | 3.37973118 |
| 69 | retina homeostasis (GO:0001895) | 3.36047283 |
| 70 | pantothenate metabolic process (GO:0015939) | 3.35918622 |
| 71 | valine metabolic process (GO:0006573) | 3.33172083 |
| 72 | negative regulation of transcription by competitive promoter binding (GO:0010944) | 3.32698884 |
| 73 | positive regulation of natural killer cell differentiation (GO:0032825) | 3.31077708 |
| 74 | regulation of water loss via skin (GO:0033561) | 3.29071678 |
| 75 | regulation of endothelial cell differentiation (GO:0045601) | 3.24973817 |
| 76 | negative regulation of fatty acid transport (GO:2000192) | 3.23726781 |
| 77 | positive regulation of insulin-like growth factor receptor signaling pathway (GO:0043568) | 3.23476782 |
| 78 | angiogenesis involved in wound healing (GO:0060055) | 3.22294568 |
| 79 | negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class | 3.21720352 |
| 80 | regulation of autophagic vacuole assembly (GO:2000785) | 3.21682105 |
| 81 | fatty acid transmembrane transport (GO:1902001) | 3.20995864 |
| 82 | intestinal absorption (GO:0050892) | 3.20688064 |
| 83 | citrulline biosynthetic process (GO:0019240) | 3.20081881 |
| 84 | triglyceride biosynthetic process (GO:0019432) | 3.19715954 |
| 85 | regulation of p38MAPK cascade (GO:1900744) | 3.18872862 |
| 86 | epithelial cell maturation (GO:0002070) | 3.17818226 |
| 87 | mammary gland alveolus development (GO:0060749) | 3.16620497 |
| 88 | diol metabolic process (GO:0034311) | 3.14550198 |
| 89 | carnitine shuttle (GO:0006853) | 3.14071289 |
| 90 | interferon-gamma secretion (GO:0072643) | 3.13965854 |
| 91 | establishment of skin barrier (GO:0061436) | 3.12596297 |
| 92 | ethanol metabolic process (GO:0006067) | 3.11344981 |
| 93 | desmosome organization (GO:0002934) | 3.11339455 |
| 94 | regulation of toll-like receptor 4 signaling pathway (GO:0034143) | 3.10863688 |
| 95 | primary alcohol catabolic process (GO:0034310) | 3.10579544 |
| 96 | sphingoid metabolic process (GO:0046519) | 3.09038276 |
| 97 | nucleobase catabolic process (GO:0046113) | 3.09013499 |
| 98 | ear development (GO:0043583) | 3.07093176 |
| 99 | superoxide anion generation (GO:0042554) | 3.06643097 |
| 100 | nucleoside diphosphate catabolic process (GO:0009134) | 3.05158360 |
| 101 | glutathione derivative metabolic process (GO:1901685) | 3.04163025 |
| 102 | glutathione derivative biosynthetic process (GO:1901687) | 3.04163025 |
| 103 | phospholipid homeostasis (GO:0055091) | 3.03589846 |
| 104 | negative regulation of cell fate commitment (GO:0010454) | 3.03353995 |
| 105 | neutral lipid biosynthetic process (GO:0046460) | 3.03208230 |
| 106 | acylglycerol biosynthetic process (GO:0046463) | 3.03208230 |
| 107 | one-carbon compound transport (GO:0019755) | 3.03030199 |
| 108 | positive regulation of macrophage cytokine production (GO:0060907) | 3.02524523 |
| 109 | response to phenylpropanoid (GO:0080184) | 3.02302021 |
| 110 | mitochondrial calcium ion transport (GO:0006851) | 3.02173746 |
| 111 | positive regulation of toll-like receptor signaling pathway (GO:0034123) | 2.98908217 |
| 112 | ceramide catabolic process (GO:0046514) | 2.96841055 |
| 113 | multicellular organismal water homeostasis (GO:0050891) | 2.96452356 |
| 114 | peptide biosynthetic process (GO:0043043) | 2.96399510 |
| 115 | acetyl-CoA metabolic process (GO:0006084) | 2.93906716 |
| 116 | regulation of triglyceride biosynthetic process (GO:0010866) | 2.91220226 |
| 117 | hydrogen peroxide biosynthetic process (GO:0050665) | 2.91201730 |
| 118 | positive regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902043) | 2.90419537 |
| 119 | regulation of macrophage cytokine production (GO:0010935) | 2.89917831 |
| 120 | detection of molecule of bacterial origin (GO:0032490) | 2.89652641 |
| 121 | response to progesterone (GO:0032570) | 2.86949097 |
| 122 | zinc ion transport (GO:0006829) | 2.85500074 |
| 123 | GDP-mannose metabolic process (GO:0019673) | 2.85096381 |
| 124 | regulation of fatty acid oxidation (GO:0046320) | 2.84244557 |
| 125 | regulation of interleukin-13 production (GO:0032656) | 2.83516323 |
| 126 | nucleotide transmembrane transport (GO:1901679) | 2.82927281 |
| 127 | activation of transmembrane receptor protein tyrosine kinase activity (GO:0007171) | 2.80458564 |
| 128 | protein O-linked glycosylation (GO:0006493) | 2.80432228 |
| 129 | regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator | 2.80268091 |
| 130 | positive regulation of sodium ion transmembrane transporter activity (GO:2000651) | 2.79484438 |
| 131 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.77546481 |
| 132 | endocrine hormone secretion (GO:0060986) | 2.76703530 |
| 133 | cardiac right ventricle morphogenesis (GO:0003215) | 2.76459830 |
| 134 | amino-acid betaine metabolic process (GO:0006577) | 2.76286332 |
| 135 | carnitine metabolic process (GO:0009437) | 2.75795817 |
| 136 | negative regulation of systemic arterial blood pressure (GO:0003085) | 2.75385284 |
| 137 | phosphatidylethanolamine acyl-chain remodeling (GO:0036152) | 2.73661682 |
| 138 | xenobiotic catabolic process (GO:0042178) | 2.73120894 |
| 139 | regulation of triglyceride metabolic process (GO:0090207) | 2.72040242 |
| 140 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 2.70138281 |
| 141 | gland morphogenesis (GO:0022612) | 2.70102912 |
| 142 | trivalent inorganic anion homeostasis (GO:0072506) | 2.69711518 |
| 143 | phosphate ion homeostasis (GO:0055062) | 2.69711518 |
| 144 | proline biosynthetic process (GO:0006561) | 2.69083280 |
| 145 | dicarboxylic acid catabolic process (GO:0043649) | 2.68983227 |
| 146 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules (GO:0016338) | 2.68970600 |
| 147 | transcytosis (GO:0045056) | 2.68854929 |
| 148 | phasic smooth muscle contraction (GO:0014821) | 2.68677669 |
| 149 | DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 cla | 2.68048071 |
| 150 | lung lobe morphogenesis (GO:0060463) | 2.67654683 |
| 151 | endocardial cushion morphogenesis (GO:0003203) | 2.66542846 |
| 152 | positive regulation of tissue remodeling (GO:0034105) | 2.64906621 |
| 153 | long-chain fatty acid transport (GO:0015909) | 2.63307594 |
| 154 | cellular response to vitamin D (GO:0071305) | 2.62013465 |
| 155 | regulation of acrosome reaction (GO:0060046) | 2.60040207 |
| 156 | detection of chemical stimulus involved in sensory perception of bitter taste (GO:0001580) | 2.58711643 |
| 157 | water homeostasis (GO:0030104) | 2.58292066 |
| 158 | reactive oxygen species biosynthetic process (GO:1903409) | 2.58039635 |
| 159 | axoneme assembly (GO:0035082) | 2.57048536 |
| 160 | cell differentiation involved in metanephros development (GO:0072202) | 2.54151575 |
| 161 | L-serine transport (GO:0015825) | 2.52833594 |
| 162 | pattern specification involved in kidney development (GO:0061004) | 11.3639016 |
| 163 | oligosaccharide biosynthetic process (GO:0009312) | 10.3526335 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 7.92877828 |
| 2 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 5.48701192 |
| 3 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 5.45083236 |
| 4 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 4.30054430 |
| 5 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 3.60029521 |
| 6 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 3.07722276 |
| 7 | ELF5_23300383_ChIP-Seq_T47D_Human | 2.92790995 |
| 8 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 2.65674945 |
| 9 | AR_21572438_ChIP-Seq_LNCaP_Human | 2.60741745 |
| 10 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 2.57950386 |
| 11 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 2.49775418 |
| 12 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.46155555 |
| 13 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 2.36701164 |
| 14 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.31910761 |
| 15 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 2.23331347 |
| 16 | SOX2_20726797_ChIP-Seq_SW620_Human | 2.23040107 |
| 17 | ZNF263_19887448_ChIP-Seq_K562_Human | 2.17546474 |
| 18 | VDR_22108803_ChIP-Seq_LS180_Human | 2.14454426 |
| 19 | AHR_22903824_ChIP-Seq_MCF-7_Human | 2.07087957 |
| 20 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 2.02395619 |
| 21 | HOXB7_26014856_ChIP-Seq_BT474_Human | 2.02063417 |
| 22 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 2.01620653 |
| 23 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.96514266 |
| 24 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.90186618 |
| 25 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.88393361 |
| 26 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.84390758 |
| 27 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.81938235 |
| 28 | * CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.81726177 |
| 29 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.76912596 |
| 30 | KDM5A_27292631_Chip-Seq_BREAST_Human | 1.73327300 |
| 31 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.64097784 |
| 32 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.62588827 |
| 33 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.62007023 |
| 34 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.57828076 |
| 35 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.55526197 |
| 36 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.55158147 |
| 37 | KLF5_25053715_ChIP-Seq_YYC3_Human | 1.53496746 |
| 38 | * SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.52626636 |
| 39 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.51817603 |
| 40 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.48533704 |
| 41 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.46197179 |
| 42 | TDRD3_21172665_ChIP-Seq_MCF-7_Human | 1.45839253 |
| 43 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.44807176 |
| 44 | FLI1_21867929_ChIP-Seq_CD8_Mouse | 1.44403387 |
| 45 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.43687312 |
| 46 | PKCTHETA_26484144_Chip-Seq_BREAST_Human | 1.42202747 |
| 47 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.41920287 |
| 48 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.40761196 |
| 49 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 1.40309690 |
| 50 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.38093691 |
| 51 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.37696619 |
| 52 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.36827332 |
| 53 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 1.33521019 |
| 54 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.32419186 |
| 55 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.32419186 |
| 56 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.28034859 |
| 57 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.27174363 |
| 58 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.26022480 |
| 59 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.24473531 |
| 60 | STAT1_20625510_ChIP-Seq_HELA_Human | 1.20109873 |
| 61 | AR_20517297_ChIP-Seq_VCAP_Human | 1.19171628 |
| 62 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 1.15322880 |
| 63 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.14684474 |
| 64 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.13949487 |
| 65 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.11757504 |
| 66 | * CJUN_26792858_Chip-Seq_BT549_Human | 1.10535927 |
| 67 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.10424658 |
| 68 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 1.10320514 |
| 69 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 1.10320514 |
| 70 | * CBP_21632823_ChIP-Seq_H3396_Human | 1.08963912 |
| 71 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 1.08111280 |
| 72 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.07728452 |
| 73 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.07594625 |
| 74 | TP63_23658742_ChIP-Seq_EP156T_Human | 1.07375827 |
| 75 | * EOMES_20176728_ChIP-ChIP_TSCs_Mouse | 1.06024557 |
| 76 | P53_21459846_ChIP-Seq_SAOS-2_Human | 1.04834956 |
| 77 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.03993221 |
| 78 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.03935059 |
| 79 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.02813556 |
| 80 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.01886229 |
| 81 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.01604077 |
| 82 | FOXH1_21741376_ChIP-Seq_ESCs_Human | 1.01240943 |
| 83 | * FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 1.01147499 |
| 84 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.00479250 |
| 85 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.00479250 |
| 86 | AR_25329375_ChIP-Seq_VCAP_Human | 0.98693677 |
| 87 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.97136503 |
| 88 | ERG_20517297_ChIP-Seq_VCAP_Human | 0.96758375 |
| 89 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 0.95824770 |
| 90 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.95285134 |
| 91 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.94481631 |
| 92 | NANOG_19829295_ChIP-Seq_ESCs_Human | 0.94065825 |
| 93 | SOX2_19829295_ChIP-Seq_ESCs_Human | 0.94065825 |
| 94 | TCF4_22108803_ChIP-Seq_LS180_Human | 0.93557978 |
| 95 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.93510581 |
| 96 | CBP_20019798_ChIP-Seq_JUKART_Human | 0.93486219 |
| 97 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 0.93486219 |
| 98 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 0.93424958 |
| 99 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 0.93379551 |
| 100 | HTT_18923047_ChIP-ChIP_STHdh_Human | 0.91381571 |
| 101 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.90860871 |
| 102 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.90605684 |
| 103 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.90082456 |
| 104 | GATA1_22025678_ChIP-Seq_K562_Human | 0.89599313 |
| 105 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 0.87986396 |
| 106 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 0.87141577 |
| 107 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.87141220 |
| 108 | NANOG_20526341_ChIP-Seq_ESCs_Human | 0.86387458 |
| 109 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 0.85692659 |
| 110 | NEUROD2_26341353_ChIP-Seq_CORTEX_Mouse | 0.85291783 |
| 111 | * RACK7_27058665_Chip-Seq_MCF-7_Human | 0.84907170 |
| 112 | TRIM28_17542650_ChIP-ChIP_NTERA2_Human | 0.84692320 |
| 113 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 0.84502823 |
| 114 | RAC3_21632823_ChIP-Seq_H3396_Human | 0.84034113 |
| 115 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.83940985 |
| 116 | SMC4_20622854_ChIP-Seq_HELA_Human | 0.83775929 |
| 117 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.83138668 |
| 118 | STAT1_17558387_ChIP-Seq_HELA_Human | 0.83080970 |
| 119 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 0.82937812 |
| 120 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 0.82865307 |
| 121 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.82104148 |
| 122 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.81956804 |
| 123 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 0.81567939 |
| 124 | ERA_21632823_ChIP-Seq_H3396_Human | 0.81031061 |
| 125 | * RXR_22108803_ChIP-Seq_LS180_Human | 0.80753516 |
| 126 | OCT4_20526341_ChIP-Seq_ESCs_Human | 0.80659014 |
| 127 | TP63_22573176_ChIP-Seq_HFKS_Human | 0.80656149 |
| 128 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 0.79901795 |
| 129 | TP53_16413492_ChIP-PET_HCT116_Human | 0.79546657 |
| 130 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 0.79148050 |
| 131 | GATA3_21878914_ChIP-Seq_MCF-7_Human | 0.78727721 |
| 132 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 0.78572666 |
| 133 | * LMO2_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.78422120 |
| 134 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.78060492 |
| 135 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 0.77133072 |
| 136 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 0.76878490 |
| 137 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.76004525 |
| 138 | TAF2_19829295_ChIP-Seq_ESCs_Human | 0.75724046 |
| 139 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.75479891 |
| 140 | CEBPA_26348894_ChIP-Seq_LIVER_Mouse | 0.75415158 |
| 141 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 0.74932410 |
| 142 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.74256307 |
| 143 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 0.74014326 |
| 144 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.72879253 |
| 145 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.72503665 |
| 146 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 0.72306522 |
| 147 | STAT3_24763339_ChIP-Seq_IMN-ESCs_Mouse | 0.72211318 |
| 148 | TAL1_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.71010493 |
| 149 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.70272536 |
| 150 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.69878582 |
| 151 | * PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 0.69413859 |
| 152 | * SOX2_18555785_Chip-Seq_ESCs_Mouse | 0.69400053 |
| 153 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.68632277 |
| 154 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 0.68273411 |
| 155 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.68135782 |
| 156 | CHD1_26751641_Chip-Seq_LNCaP_Human | 0.67360324 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003136_yellow_coat_color | 4.54086315 |
| 2 | MP0010234_abnormal_vibrissa_follicle | 4.51261745 |
| 3 | MP0002254_reproductive_system_inflammat | 3.15871262 |
| 4 | * MP0000627_abnormal_mammary_gland | 3.13194589 |
| 5 | MP0004264_abnormal_extraembryonic_tissu | 2.95105393 |
| 6 | MP0002098_abnormal_vibrissa_morphology | 2.70583491 |
| 7 | MP0001873_stomach_inflammation | 2.64798541 |
| 8 | MP0000566_synostosis | 2.48791413 |
| 9 | MP0002009_preneoplasia | 2.46926614 |
| 10 | MP0004019_abnormal_vitamin_homeostasis | 2.39521817 |
| 11 | MP0004147_increased_porphyrin_level | 2.39483745 |
| 12 | MP0002796_impaired_skin_barrier | 2.10453801 |
| 13 | MP0003300_gastrointestinal_ulcer | 2.00607862 |
| 14 | * MP0001881_abnormal_mammary_gland | 10.2060815 |
| 15 | MP0003718_maternal_effect | 1.99897592 |
| 16 | MP0005171_absent_coat_pigmentation | 1.96436880 |
| 17 | MP0004043_abnormal_pH_regulation | 1.94512279 |
| 18 | MP0005379_endocrine/exocrine_gland_phen | 1.89086735 |
| 19 | MP0004782_abnormal_surfactant_physiolog | 1.82788408 |
| 20 | MP0004381_abnormal_hair_follicle | 1.81224028 |
| 21 | MP0003011_delayed_dark_adaptation | 1.78180265 |
| 22 | MP0010678_abnormal_skin_adnexa | 1.75112933 |
| 23 | MP0005083_abnormal_biliary_tract | 1.68191614 |
| 24 | MP0000377_abnormal_hair_follicle | 1.54801312 |
| 25 | MP0008789_abnormal_olfactory_epithelium | 1.53048431 |
| 26 | MP0001346_abnormal_lacrimal_gland | 1.48050680 |
| 27 | MP0001664_abnormal_digestion | 1.42675817 |
| 28 | MP0005394_taste/olfaction_phenotype | 1.42411145 |
| 29 | MP0005499_abnormal_olfactory_system | 1.42411145 |
| 30 | MP0004130_abnormal_muscle_cell | 1.42075285 |
| 31 | MP0003303_peritoneal_inflammation | 1.37745966 |
| 32 | MP0002277_abnormal_respiratory_mucosa | 1.34458651 |
| 33 | MP0005410_abnormal_fertilization | 1.34389013 |
| 34 | MP0000579_abnormal_nail_morphology | 1.30977706 |
| 35 | MP0010386_abnormal_urinary_bladder | 1.30718069 |
| 36 | MP0005085_abnormal_gallbladder_physiolo | 1.30076348 |
| 37 | MP0005670_abnormal_white_adipose | 1.29566504 |
| 38 | MP0009780_abnormal_chondrocyte_physiolo | 1.28977723 |
| 39 | MP0001727_abnormal_embryo_implantation | 1.26451869 |
| 40 | MP0005646_abnormal_pituitary_gland | 1.25955017 |
| 41 | MP0000762_abnormal_tongue_morphology | 1.25315795 |
| 42 | MP0002060_abnormal_skin_morphology | 1.24165901 |
| 43 | MP0001177_atelectasis | 1.22428571 |
| 44 | MP0005501_abnormal_skin_physiology | 1.21239340 |
| 45 | MP0002653_abnormal_ependyma_morphology | 1.21012206 |
| 46 | MP0005395_other_phenotype | 1.18612274 |
| 47 | MP0003195_calcinosis | 1.18590828 |
| 48 | MP0000383_abnormal_hair_follicle | 1.15824860 |
| 49 | MP0001958_emphysema | 1.15823352 |
| 50 | MP0002876_abnormal_thyroid_physiology | 1.12300759 |
| 51 | MP0000613_abnormal_salivary_gland | 1.07523007 |
| 52 | MP0005310_abnormal_salivary_gland | 1.06927967 |
| 53 | MP0001216_abnormal_epidermal_layer | 1.05473959 |
| 54 | MP0000490_abnormal_crypts_of | 1.02613779 |
| 55 | MP0005275_abnormal_skin_tensile | 1.01484586 |
| 56 | MP0005075_abnormal_melanosome_morpholog | 0.96580713 |
| 57 | MP0001663_abnormal_digestive_system | 0.96391691 |
| 58 | MP0005408_hypopigmentation | 0.94480907 |
| 59 | MP0003566_abnormal_cell_adhesion | 0.94134640 |
| 60 | MP0005666_abnormal_adipose_tissue | 0.93852637 |
| 61 | MP0003453_abnormal_keratinocyte_physiol | 0.92846900 |
| 62 | MP0005389_reproductive_system_phenotype | 0.88823048 |
| 63 | MP0005645_abnormal_hypothalamus_physiol | 0.87579264 |
| 64 | MP0005381_digestive/alimentary_phenotyp | 0.87122911 |
| 65 | MP0005636_abnormal_mineral_homeostasis | 0.87015173 |
| 66 | MP0004272_abnormal_basement_membrane | 0.86317630 |
| 67 | MP0003638_abnormal_response/metabolism_ | 0.85137672 |
| 68 | MP0001666_abnormal_nutrient_absorption | 0.82488436 |
| 69 | * MP0003936_abnormal_reproductive_system | 0.82046869 |
| 70 | MP0003448_altered_tumor_morphology | 0.79152989 |
| 71 | MP0008875_abnormal_xenobiotic_pharmacok | 0.78792029 |
| 72 | MP0001765_abnormal_ion_homeostasis | 0.77937663 |
| 73 | MP0002133_abnormal_respiratory_system | 0.77638642 |
| 74 | MP0005388_respiratory_system_phenotype | 0.77638642 |
| 75 | MP0002896_abnormal_bone_mineralization | 0.76947481 |
| 76 | MP0000427_abnormal_hair_cycle | 0.76858814 |
| 77 | MP0008995_early_reproductive_senescence | 0.76580445 |
| 78 | MP0002132_abnormal_respiratory_system | 0.76316955 |
| 79 | MP0000367_abnormal_coat/_hair | 0.76293355 |
| 80 | MP0000678_abnormal_parathyroid_gland | 0.75435736 |
| 81 | MP0005551_abnormal_eye_electrophysiolog | 0.74600331 |
| 82 | MP0002396_abnormal_hematopoietic_system | 0.74371658 |
| 83 | MP0002909_abnormal_adrenal_gland | 0.74346408 |
| 84 | MP0005248_abnormal_Harderian_gland | 0.74243203 |
| 85 | MP0003787_abnormal_imprinting | 0.73918539 |
| 86 | MP0009384_cardiac_valve_regurgitation | 0.73823819 |
| 87 | MP0003183_abnormal_peptide_metabolism | 0.73272228 |
| 88 | MP0005375_adipose_tissue_phenotype | 0.72667623 |
| 89 | MP0000470_abnormal_stomach_morphology | 0.71129220 |
| 90 | MP0008438_abnormal_cutaneous_collagen | 0.70994316 |
| 91 | MP0000858_altered_metastatic_potential | 0.69736990 |
| 92 | MP0004233_abnormal_muscle_weight | 0.69656588 |
| 93 | MP0004742_abnormal_vestibular_system | 0.69272955 |
| 94 | MP0000647_abnormal_sebaceous_gland | 0.69112358 |
| 95 | MP0010771_integument_phenotype | 0.68397956 |
| 96 | MP0000681_abnormal_thyroid_gland | 0.68327492 |
| 97 | MP0005334_abnormal_fat_pad | 0.67945445 |
| 98 | MP0005647_abnormal_sex_gland | 0.67636481 |
| 99 | MP0001919_abnormal_reproductive_system | 0.67497305 |
| 100 | MP0002295_abnormal_pulmonary_circulatio | 0.66646780 |
| 101 | MP0010352_gastrointestinal_tract_polyps | 0.66606890 |
| 102 | MP0002148_abnormal_hypersensitivity_rea | 0.66541083 |
| 103 | MP0005365_abnormal_bile_salt | 0.65601475 |
| 104 | MP0000462_abnormal_digestive_system | 0.65511891 |
| 105 | MP0001756_abnormal_urination | 0.64582606 |
| 106 | MP0010329_abnormal_lipoprotein_level | 0.63796482 |
| 107 | MP0002168_other_aberrant_phenotype | 0.63696184 |
| 108 | MP0002118_abnormal_lipid_homeostasis | 0.63508222 |
| 109 | MP0001849_ear_inflammation | 0.63148889 |
| 110 | MP0002233_abnormal_nose_morphology | 0.62991385 |
| 111 | MP0001984_abnormal_olfaction | 0.62457802 |
| 112 | MP0003959_abnormal_lean_body | 0.62335527 |
| 113 | MP0001851_eye_inflammation | 0.61945043 |
| 114 | MP0000516_abnormal_urinary_system | 0.61563951 |
| 115 | MP0005367_renal/urinary_system_phenotyp | 0.61563951 |
| 116 | MP0003191_abnormal_cellular_cholesterol | 0.61228342 |
| 117 | MP0003045_fibrosis | 0.61061972 |
| 118 | MP0005058_abnormal_lysosome_morphology | 0.60649190 |
| 119 | MP0002282_abnormal_trachea_morphology | 0.60335586 |
| 120 | MP0001188_hyperpigmentation | 0.59841333 |
| 121 | MP0002166_altered_tumor_susceptibility | 0.59192690 |
| 122 | MP0005220_abnormal_exocrine_pancreas | 0.58887408 |
| 123 | MP0000538_abnormal_urinary_bladder | 0.58367963 |
| 124 | MP0008961_abnormal_basal_metabolism | 0.58331378 |
| 125 | MP0008872_abnormal_physiological_respon | 0.57697153 |
| 126 | MP0009643_abnormal_urine_homeostasis | 0.56844372 |
| 127 | MP0005076_abnormal_cell_differentiation | 0.55782903 |
| 128 | MP0002998_abnormal_bone_remodeling | 0.53813981 |
| 129 | MP0004947_skin_inflammation | 0.53404043 |
| 130 | MP0002160_abnormal_reproductive_system | 0.53385415 |
| 131 | MP0003953_abnormal_hormone_level | 0.51897695 |
| 132 | MP0002693_abnormal_pancreas_physiology | 0.49239186 |
| 133 | MP0002751_abnormal_autonomic_nervous | 0.48787489 |
| 134 | MP0001502_abnormal_circadian_rhythm | 0.48253491 |
| 135 | MP0003938_abnormal_ear_development | 0.47897761 |
| 136 | MP0000631_abnormal_neuroendocrine_gland | 0.47730896 |
| 137 | MP0000371_diluted_coat_color | 0.47043355 |
| 138 | MP0005332_abnormal_amino_acid | 0.46925233 |
| 139 | MP0000537_abnormal_urethra_morphology | 0.46371500 |
| 140 | MP0002078_abnormal_glucose_homeostasis | 0.46155842 |
| 141 | MP0006276_abnormal_autonomic_nervous | 0.45686180 |
| 142 | MP0008004_abnormal_stomach_pH | 0.45283355 |
| 143 | MP0001944_abnormal_pancreas_morphology | 0.45025459 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Concave nail (HP:0001598) | 6.31836616 |
| 2 | Amelogenesis imperfecta (HP:0000705) | 5.59743026 |
| 3 | Curly hair (HP:0002212) | 4.90026336 |
| 4 | Congenital ichthyosiform erythroderma (HP:0007431) | 4.89888897 |
| 5 | Pili torti (HP:0003777) | 4.84214493 |
| 6 | Right ventricular cardiomyopathy (HP:0011663) | 4.64436549 |
| 7 | Flat capital femoral epiphysis (HP:0003370) | 4.58322777 |
| 8 | Tubulointerstitial nephritis (HP:0001970) | 4.33587605 |
| 9 | Hyperactive renin-angiotensin system (HP:0000841) | 4.13658828 |
| 10 | Abnormality of purine metabolism (HP:0004352) | 4.06105652 |
| 11 | Onycholysis (HP:0001806) | 3.99342535 |
| 12 | Decreased circulating renin level (HP:0003351) | 3.90114601 |
| 13 | Ectropion (HP:0000656) | 3.87584266 |
| 14 | Abnormality of the proximal phalanges of the hand (HP:0009834) | 3.82820427 |
| 15 | Aplasia cutis congenita (HP:0001057) | 3.55998914 |
| 16 | Atrophic scars (HP:0001075) | 3.48124164 |
| 17 | Lip pit (HP:0100267) | 3.40790496 |
| 18 | White forelock (HP:0002211) | 3.40526869 |
| 19 | Abnormality of renal resorption (HP:0011038) | 3.30707029 |
| 20 | Milia (HP:0001056) | 3.29153195 |
| 21 | Overgrowth (HP:0001548) | 3.28045618 |
| 22 | Sparse lateral eyebrow (HP:0005338) | 3.26658440 |
| 23 | Enlarged epiphyses (HP:0010580) | 3.19616434 |
| 24 | Abnormality of renal excretion (HP:0011036) | 3.18017488 |
| 25 | Morphological abnormality of the inner ear (HP:0011390) | 3.14733717 |
| 26 | Abnormality of calcium-phosphate metabolism (HP:0100530) | 3.11605953 |
| 27 | Vacuolated lymphocytes (HP:0001922) | 3.05634002 |
| 28 | Patchy hypopigmentation of hair (HP:0011365) | 3.01989858 |
| 29 | Blepharitis (HP:0000498) | 2.97329473 |
| 30 | Abnormality of the dental pulp (HP:0006479) | 2.94237381 |
| 31 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 2.93911171 |
| 32 | Chronic bronchitis (HP:0004469) | 2.93176181 |
| 33 | Infantile muscular hypotonia (HP:0008947) | 2.92580891 |
| 34 | Hypoplasia of dental enamel (HP:0006297) | 2.90461573 |
| 35 | Gout (HP:0001997) | 2.89850258 |
| 36 | Nephritis (HP:0000123) | 2.89849355 |
| 37 | Hypoplasia of the iris (HP:0007676) | 2.88629465 |
| 38 | Subcapsular cataract (HP:0000523) | 2.88399084 |
| 39 | Abnormal hair laboratory examination (HP:0003328) | 2.81455767 |
| 40 | Axonal loss (HP:0003447) | 2.79127700 |
| 41 | Exostoses (HP:0100777) | 2.74670156 |
| 42 | Metaphyseal dysplasia (HP:0100255) | 2.72351780 |
| 43 | Oligomenorrhea (HP:0000876) | 2.71491232 |
| 44 | Hypokalemic alkalosis (HP:0001949) | 2.71151963 |
| 45 | Microretrognathia (HP:0000308) | 2.68352165 |
| 46 | Aortic aneurysm (HP:0004942) | 2.65739618 |
| 47 | Widely patent fontanelles and sutures (HP:0004492) | 2.65194109 |
| 48 | Tubulointerstitial fibrosis (HP:0005576) | 2.64725724 |
| 49 | Hyperkalemia (HP:0002153) | 2.62080171 |
| 50 | Stomach cancer (HP:0012126) | 2.56978909 |
| 51 | Hyperglycinuria (HP:0003108) | 2.55916767 |
| 52 | Abnormality of the renal medulla (HP:0100957) | 2.53754150 |
| 53 | Hamartoma of the eye (HP:0010568) | 2.51902992 |
| 54 | Hyperaldosteronism (HP:0000859) | 2.47947777 |
| 55 | Abnormal tarsal ossification (HP:0008369) | 2.46916274 |
| 56 | Abnormality of the axillary hair (HP:0100134) | 2.46904400 |
| 57 | Abnormality of secondary sexual hair (HP:0009888) | 2.46904400 |
| 58 | Long toe (HP:0010511) | 2.44763454 |
| 59 | Abnormality of renin-angiotensin system (HP:0000847) | 2.44587227 |
| 60 | Abnormality of nucleobase metabolism (HP:0010932) | 2.43935090 |
| 61 | Breast carcinoma (HP:0003002) | 2.42371530 |
| 62 | Abnormality of cochlea (HP:0000375) | 2.42115284 |
| 63 | Thin bony cortex (HP:0002753) | 2.38320573 |
| 64 | Interstitial pulmonary disease (HP:0006530) | 2.37476069 |
| 65 | Abnormality of dental color (HP:0011073) | 2.34896064 |
| 66 | Flat acetabular roof (HP:0003180) | 2.31805737 |
| 67 | Hypoplasia of the pons (HP:0012110) | 2.30080549 |
| 68 | Renal salt wasting (HP:0000127) | 2.28991965 |
| 69 | Premature skin wrinkling (HP:0100678) | 2.26410553 |
| 70 | Aortic dissection (HP:0002647) | 2.26058339 |
| 71 | Alopecia of scalp (HP:0002293) | 2.25218497 |
| 72 | Hypohidrosis (HP:0000966) | 2.23497862 |
| 73 | Ketoacidosis (HP:0001993) | 2.22729856 |
| 74 | Deep philtrum (HP:0002002) | 2.22350346 |
| 75 | Popliteal pterygium (HP:0009756) | 2.22233221 |
| 76 | Abnormality of the pons (HP:0007361) | 2.19087768 |
| 77 | Nail dystrophy (HP:0008404) | 2.17756528 |
| 78 | Tongue fasciculations (HP:0001308) | 2.16574419 |
| 79 | Severe Myopia (HP:0011003) | 2.16433307 |
| 80 | Germ cell neoplasia (HP:0100728) | 2.16402092 |
| 81 | Septate vagina (HP:0001153) | 2.16103918 |
| 82 | Asymmetry of the thorax (HP:0001555) | 2.15646945 |
| 83 | Premature loss of primary teeth (HP:0006323) | 2.15324802 |
| 84 | Ketosis (HP:0001946) | 2.13234027 |
| 85 | Abnormality of the parathyroid morphology (HP:0011766) | 2.12515948 |
| 86 | Tubulointerstitial abnormality (HP:0001969) | 2.12416241 |
| 87 | Congenital, generalized hypertrichosis (HP:0004540) | 2.12127499 |
| 88 | Pancreatic cysts (HP:0001737) | 2.11968379 |
| 89 | Stridor (HP:0010307) | 2.11817248 |
| 90 | Abnormality of the renal collecting system (HP:0004742) | 2.11172375 |
| 91 | Type II lissencephaly (HP:0007260) | 2.11010992 |
| 92 | Osteolytic defects of the hand bones (HP:0009699) | 2.09849543 |
| 93 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.09849543 |
| 94 | Glomerulosclerosis (HP:0000096) | 2.06518204 |
| 95 | Fragile nails (HP:0001808) | 2.06375196 |
| 96 | Renal tubular acidosis (HP:0001947) | 2.06072303 |
| 97 | Abnormality of chloride homeostasis (HP:0011422) | 2.05164127 |
| 98 | Facial shape deformation (HP:0011334) | 2.04987332 |
| 99 | Potter facies (HP:0002009) | 2.04987332 |
| 100 | Abnormality of the renal cortex (HP:0011035) | 2.04624904 |
| 101 | Epiphyseal stippling (HP:0010655) | 2.02581046 |
| 102 | Woolly hair (HP:0002224) | 2.02042125 |
| 103 | Abnormality of the epiphyses of the phalanges of the hand (HP:0005920) | 2.01198389 |
| 104 | Macroorchidism (HP:0000053) | 2.00878390 |
| 105 | Shawl scrotum (HP:0000049) | 2.00776837 |
| 106 | Abnormality of the epiphysis of the femoral head (HP:0010574) | 2.00140042 |
| 107 | Abnormality of the femoral head (HP:0003368) | 1.99677512 |
| 108 | Hydronephrosis (HP:0000126) | 1.99344344 |
| 109 | Exotropia (HP:0000577) | 1.98703847 |
| 110 | Abnormality of nail color (HP:0100643) | 1.98394304 |
| 111 | Aplasia/Hypoplasia of the scapulae (HP:0006713) | 1.97026806 |
| 112 | Hypoplastic scapulae (HP:0000882) | 1.97026806 |
| 113 | Plantar hyperkeratosis (HP:0007556) | 1.96978155 |
| 114 | Anterior segment dysgenesis (HP:0007700) | 1.93407804 |
| 115 | True hermaphroditism (HP:0010459) | 1.91581523 |
| 116 | Hypotrichosis (HP:0001006) | 1.91557687 |
| 117 | Syncope (HP:0001279) | 1.90519092 |
| 118 | Absent eyelashes (HP:0000561) | 1.89984553 |
| 119 | Nasolacrimal duct obstruction (HP:0000579) | 1.89208599 |
| 120 | Abnormality of the nasal septum (HP:0000419) | 1.88689869 |
| 121 | Aplasia of the musculature (HP:0100854) | 1.88379116 |
| 122 | Heterochromia iridis (HP:0001100) | 1.87402489 |
| 123 | Cystic liver disease (HP:0006706) | 1.86249610 |
| 124 | Hypothermia (HP:0002045) | 1.85861922 |
| 125 | Long foot (HP:0001833) | 1.85843395 |
| 126 | Corneal erosion (HP:0200020) | 1.85518594 |
| 127 | Abnormal epiphyseal ossification (HP:0010656) | 1.84809824 |
| 128 | Cone-shaped epiphyses of the phalanges of the hand (HP:0010230) | 1.83007106 |
| 129 | Abnormal auditory evoked potentials (HP:0006958) | 1.82066334 |
| 130 | Congenital stationary night blindness (HP:0007642) | 1.81663415 |
| 131 | Pruritus (HP:0000989) | 1.81403285 |
| 132 | Bone pain (HP:0002653) | 1.81013003 |
| 133 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 1.80011561 |
| 134 | Astrocytoma (HP:0009592) | 1.79977549 |
| 135 | Abnormality of the astrocytes (HP:0100707) | 1.79977549 |
| 136 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 1.79737830 |
| 137 | Abnormal hemoglobin (HP:0011902) | 1.78949075 |
| 138 | Abnormality of glycine metabolism (HP:0010895) | 1.78926959 |
| 139 | Abnormality of serine family amino acid metabolism (HP:0010894) | 1.78926959 |
| 140 | Reduced antithrombin III activity (HP:0001976) | 1.78030706 |
| 141 | Tinnitus (HP:0000360) | 1.76950380 |
| 142 | Akinesia (HP:0002304) | 1.76535369 |
| 143 | Autoamputation (HP:0001218) | 1.75894904 |
| 144 | Ependymoma (HP:0002888) | 1.75602979 |
| 145 | Glioma (HP:0009733) | 1.75166374 |
| 146 | Tubular atrophy (HP:0000092) | 1.74450582 |
| 147 | Molar tooth sign on MRI (HP:0002419) | 1.74347116 |
| 148 | Abnormality of midbrain morphology (HP:0002418) | 1.74347116 |
| 149 | Abdominal distention (HP:0003270) | 1.73691480 |
| 150 | Testicular atrophy (HP:0000029) | 1.73401290 |
| 151 | Bronchitis (HP:0012387) | 1.73240268 |
| 152 | Lymphangioma (HP:0100764) | 1.73043167 |
| 153 | Abnormality involving the epiphyses of the lower limbs (HP:0006500) | 1.71571056 |
| 154 | Abnormality of femoral epiphyses (HP:0006499) | 1.71571056 |
| 155 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 1.71562547 |
| 156 | Absent/shortened dynein arms (HP:0200106) | 1.71562547 |
| 157 | Abnormality of the anterior chamber (HP:0000593) | 1.71504352 |
| 158 | Hyperphosphatemia (HP:0002905) | 1.70257031 |
| 159 | Vascular calcification (HP:0004934) | 1.70239542 |
| 160 | Cone-rod dystrophy (HP:0000548) | 1.69989667 |
| 161 | Clumsiness (HP:0002312) | 1.68773107 |
| 162 | Infertility (HP:0000789) | 1.68689849 |
| 163 | Polar cataract (HP:0010696) | 1.68425930 |
| 164 | Protuberant abdomen (HP:0001538) | 1.67891538 |
| 165 | Urethral obstruction (HP:0000796) | 1.67872335 |
| 166 | Chronic sinusitis (HP:0011109) | 1.67782555 |
| 167 | Abnormality of the epiphyses of the hand (HP:0005924) | 1.67242520 |
| 168 | Abnormality of proline metabolism (HP:0010907) | 1.67007311 |
| 169 | Hydroxyprolinuria (HP:0003080) | 1.67007311 |
| 170 | Abnormality of the distal phalanges of the toes (HP:0010182) | 1.66718059 |
| 171 | Hypoplastic ischia (HP:0003175) | 1.66404085 |
| 172 | Furrowed tongue (HP:0000221) | 1.65845856 |
| 173 | Mucopolysacchariduria (HP:0008155) | 1.65307719 |
| 174 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.65307719 |
| 175 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 1.64820896 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | SIK1 | 6.33192922 |
| 2 | CAMK1D | 4.08363480 |
| 3 | AKT3 | 3.66477014 |
| 4 | CAMK1G | 3.20590960 |
| 5 | LATS1 | 3.17993008 |
| 6 | PIK3CA | 2.58210155 |
| 7 | PDK2 | 2.41340650 |
| 8 | IRAK3 | 2.38914704 |
| 9 | NME2 | 2.32516607 |
| 10 | EPHA3 | 2.28239680 |
| 11 | EPHA2 | 2.20667572 |
| 12 | TESK1 | 2.15285565 |
| 13 | VRK2 | 2.12371397 |
| 14 | STK38L | 2.11812689 |
| 15 | MAP2K6 | 2.06151321 |
| 16 | EEF2K | 2.05214741 |
| 17 | PKN2 | 1.99751221 |
| 18 | FRK | 1.97219320 |
| 19 | EPHB1 | 1.92494940 |
| 20 | EIF2AK1 | 1.89167384 |
| 21 | ERN1 | 1.67995258 |
| 22 | PTK6 | 1.67359250 |
| 23 | STK39 | 1.63940059 |
| 24 | MYLK | 1.59066107 |
| 25 | RPS6KB2 | 1.56601883 |
| 26 | BCKDK | 1.54812738 |
| 27 | TESK2 | 1.53165667 |
| 28 | TRPM7 | 1.50375063 |
| 29 | MAPKAPK3 | 1.49837459 |
| 30 | MST4 | 1.48660755 |
| 31 | FER | 1.48068842 |
| 32 | OXSR1 | 1.47819235 |
| 33 | MAPK15 | 1.47346487 |
| 34 | MATK | 1.46815593 |
| 35 | MAP3K3 | 1.41957464 |
| 36 | ZAK | 1.39789825 |
| 37 | NLK | 1.39301409 |
| 38 | STK24 | 1.33814347 |
| 39 | PDGFRB | 1.31076600 |
| 40 | PDK4 | 1.27903606 |
| 41 | PDK3 | 1.27903606 |
| 42 | NUAK1 | 1.27300781 |
| 43 | ADRBK2 | 1.24619680 |
| 44 | BMPR1B | 1.19148778 |
| 45 | ILK | 1.13554535 |
| 46 | NEK6 | 1.10986448 |
| 47 | LIMK1 | 1.09354941 |
| 48 | ZAP70 | 1.09348060 |
| 49 | RIPK1 | 1.08378037 |
| 50 | TAOK3 | 1.04991946 |
| 51 | JAK3 | 1.03243817 |
| 52 | MAP3K14 | 1.02403496 |
| 53 | WNK3 | 1.02132580 |
| 54 | TRIB3 | 1.01697579 |
| 55 | PINK1 | 1.01651831 |
| 56 | BMX | 0.98264585 |
| 57 | SCYL2 | 0.94473118 |
| 58 | CDK12 | 0.93338025 |
| 59 | TGFBR2 | 0.90121922 |
| 60 | MAP3K2 | 0.89159516 |
| 61 | PRKAA2 | 0.89037403 |
| 62 | EIF2AK3 | 0.88660885 |
| 63 | WNK4 | 0.87197844 |
| 64 | TXK | 0.85881865 |
| 65 | STK3 | 0.84716954 |
| 66 | PIK3CG | 0.84495874 |
| 67 | TRIM28 | 0.84068607 |
| 68 | TNK2 | 0.83407031 |
| 69 | MUSK | 0.82576642 |
| 70 | IRAK4 | 0.82287523 |
| 71 | IRAK1 | 0.81854058 |
| 72 | MAP4K2 | 0.81152914 |
| 73 | EIF2AK2 | 0.80940766 |
| 74 | STK16 | 0.80747601 |
| 75 | STK38 | 0.80372712 |
| 76 | CHUK | 0.78622071 |
| 77 | INSRR | 0.78213275 |
| 78 | GRK5 | 0.76601416 |
| 79 | TSSK6 | 0.72170132 |
| 80 | BMPR2 | 0.70169637 |
| 81 | JAK1 | 0.69166323 |
| 82 | TNIK | 0.63491487 |
| 83 | PRKD1 | 0.59844622 |
| 84 | RPS6KA2 | 0.58446733 |
| 85 | PAK3 | 0.58139635 |
| 86 | CSF1R | 0.56920241 |
| 87 | TAF1 | 0.56314635 |
| 88 | SGK494 | 0.55391092 |
| 89 | SGK223 | 0.55391092 |
| 90 | RET | 0.54965164 |
| 91 | GRK6 | 0.54938034 |
| 92 | MST1R | 0.53789748 |
| 93 | ICK | 0.53646794 |
| 94 | DAPK2 | 0.53182952 |
| 95 | CAMK1 | 0.50899837 |
| 96 | MET | 0.50646984 |
| 97 | CDK7 | 0.49692165 |
| 98 | GRK1 | 0.48512199 |
| 99 | BTK | 0.47158493 |
| 100 | LRRK2 | 0.46896293 |
| 101 | CASK | 0.46243731 |
| 102 | MAP2K1 | 0.46203270 |
| 103 | TLK1 | 0.46052820 |
| 104 | CSNK1A1 | 0.45640432 |
| 105 | MAP3K12 | 0.43896502 |
| 106 | SGK2 | 0.43733551 |
| 107 | MTOR | 0.43516090 |
| 108 | ACVR1B | 0.42942531 |
| 109 | ERBB3 | 0.41768458 |
| 110 | MAP3K7 | 0.40305799 |
| 111 | IGF1R | 0.40239351 |
| 112 | GSK3A | 0.39341638 |
| 113 | TAOK1 | 0.39114376 |
| 114 | FGFR3 | 0.37888372 |
| 115 | MAP2K7 | 0.37608435 |
| 116 | NEK9 | 0.36532539 |
| 117 | JAK2 | 0.36491669 |
| 118 | EPHB2 | 0.36312182 |
| 119 | YES1 | 0.35824564 |
| 120 | PBK | 0.35532356 |
| 121 | HIPK2 | 0.35069204 |
| 122 | PRKD2 | 0.34914797 |
| 123 | PRKCE | 0.34228562 |
| 124 | CAMK2D | 0.34091639 |
| 125 | MAPKAPK5 | 0.33500594 |
| 126 | PRKCZ | 0.32422052 |
| 127 | MAPKAPK2 | 0.31737778 |
| 128 | PRKCI | 0.31266035 |
| 129 | VRK1 | 0.31156483 |
| 130 | CSNK1E | 0.31000678 |
| 131 | IKBKE | 0.30464064 |
| 132 | PTK2 | 0.29436573 |
| 133 | ERBB2 | 0.29257358 |
| 134 | MAPK12 | 0.29132161 |
| 135 | MAPK13 | 0.28594620 |
| 136 | IKBKB | 0.28318591 |
| 137 | TIE1 | 0.28093865 |
| 138 | PRKCD | 0.26665581 |
| 139 | RPS6KB1 | 0.26262484 |
| 140 | SGK3 | 0.25331933 |
| 141 | RPS6KL1 | 0.24879294 |
| 142 | RPS6KC1 | 0.24879294 |
| 143 | MAP2K2 | 0.24419976 |
| 144 | PRKAA1 | 0.24089987 |
| 145 | RPS6KA6 | 0.23506972 |
| 146 | TYK2 | 0.21145966 |
| 147 | PIM1 | 0.20472587 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 8.84744837 |
| 2 | Caffeine metabolism_Homo sapiens_hsa00232 | 8.42071925 |
| 3 | Galactose metabolism_Homo sapiens_hsa00052 | 3.26848093 |
| 4 | Protein export_Homo sapiens_hsa03060 | 2.32354056 |
| 5 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.95942663 |
| 6 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.92424312 |
| 7 | Histidine metabolism_Homo sapiens_hsa00340 | 1.82292582 |
| 8 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 1.73662223 |
| 9 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.69242261 |
| 10 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 1.67807588 |
| 11 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.66036992 |
| 12 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.52688020 |
| 13 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.51672452 |
| 14 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 1.44690600 |
| 15 | * Prolactin signaling pathway_Homo sapiens_hsa04917 | 1.43330202 |
| 16 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.38902025 |
| 17 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.38381218 |
| 18 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.34749910 |
| 19 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.17950829 |
| 20 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 1.05556907 |
| 21 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.04926346 |
| 22 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.03279173 |
| 23 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.02666622 |
| 24 | Sulfur relay system_Homo sapiens_hsa04122 | 1.02498640 |
| 25 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.97228346 |
| 26 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.96476443 |
| 27 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.95955614 |
| 28 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.94842291 |
| 29 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.94134908 |
| 30 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.91326685 |
| 31 | Mineral absorption_Homo sapiens_hsa04978 | 0.91006321 |
| 32 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.90343315 |
| 33 | Adherens junction_Homo sapiens_hsa04520 | 0.88807741 |
| 34 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.88571620 |
| 35 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.87168548 |
| 36 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.85821412 |
| 37 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.83153489 |
| 38 | ABC transporters_Homo sapiens_hsa02010 | 0.81348782 |
| 39 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.81224442 |
| 40 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.80664159 |
| 41 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.80478645 |
| 42 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.79664439 |
| 43 | Hepatitis C_Homo sapiens_hsa05160 | 0.79527302 |
| 44 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.78986114 |
| 45 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.77188658 |
| 46 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.75363512 |
| 47 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.74487835 |
| 48 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.73667778 |
| 49 | Lysosome_Homo sapiens_hsa04142 | 0.73537574 |
| 50 | Peroxisome_Homo sapiens_hsa04146 | 0.73515308 |
| 51 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.73293626 |
| 52 | Tight junction_Homo sapiens_hsa04530 | 0.73184091 |
| 53 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.70360043 |
| 54 | Phototransduction_Homo sapiens_hsa04744 | 0.69670990 |
| 55 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.69575732 |
| 56 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.66138123 |
| 57 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.64843016 |
| 58 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.63468565 |
| 59 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.63340588 |
| 60 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.63214598 |
| 61 | Taste transduction_Homo sapiens_hsa04742 | 0.62659328 |
| 62 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.62039931 |
| 63 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.59686559 |
| 64 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.58695197 |
| 65 | Endometrial cancer_Homo sapiens_hsa05213 | 0.57245717 |
| 66 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.56644515 |
| 67 | Insulin resistance_Homo sapiens_hsa04931 | 0.54216970 |
| 68 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.53958465 |
| 69 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.53494476 |
| 70 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.53412559 |
| 71 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.52492259 |
| 72 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.52113300 |
| 73 | Amoebiasis_Homo sapiens_hsa05146 | 0.49770124 |
| 74 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.49281810 |
| 75 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.49019912 |
| 76 | Measles_Homo sapiens_hsa05162 | 0.48584416 |
| 77 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.48168343 |
| 78 | Prostate cancer_Homo sapiens_hsa05215 | 0.46911863 |
| 79 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.45576948 |
| 80 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.45135032 |
| 81 | Metabolic pathways_Homo sapiens_hsa01100 | 0.44660538 |
| 82 | Phagosome_Homo sapiens_hsa04145 | 0.44566837 |
| 83 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.44534807 |
| 84 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.44515245 |
| 85 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.44465161 |
| 86 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.43436545 |
| 87 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.43030914 |
| 88 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.41122273 |
| 89 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.40282731 |
| 90 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.38429445 |
| 91 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.38033180 |
| 92 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.37614094 |
| 93 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.36424563 |
| 94 | Salivary secretion_Homo sapiens_hsa04970 | 0.36357987 |
| 95 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.36204048 |
| 96 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.35237089 |
| 97 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.35149537 |
| 98 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.34686806 |
| 99 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.34545610 |
| 100 | Melanoma_Homo sapiens_hsa05218 | 0.34127602 |
| 101 | Hepatitis B_Homo sapiens_hsa05161 | 0.33688392 |
| 102 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.33433338 |
| 103 | Influenza A_Homo sapiens_hsa05164 | 0.32262759 |
| 104 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.31412198 |
| 105 | Focal adhesion_Homo sapiens_hsa04510 | 0.30916247 |
| 106 | Other glycan degradation_Homo sapiens_hsa00511 | 0.30874724 |
| 107 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.30244220 |
| 108 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.29859694 |
| 109 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.29691814 |
| 110 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.28769790 |
| 111 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.28465412 |
| 112 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.28233011 |
| 113 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.27581377 |
| 114 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.26594927 |
| 115 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.26341827 |
| 116 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.26283313 |
| 117 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.25744471 |
| 118 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.25737582 |
| 119 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.25345045 |
| 120 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.24296909 |
| 121 | Leishmaniasis_Homo sapiens_hsa05140 | 0.24183927 |
| 122 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.23668227 |
| 123 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.23663465 |
| 124 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.23557351 |
| 125 | Lysine degradation_Homo sapiens_hsa00310 | 0.23524005 |
| 126 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.21326329 |
| 127 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.20543518 |
| 128 | Circadian rhythm_Homo sapiens_hsa04710 | 0.20151704 |
| 129 | Bladder cancer_Homo sapiens_hsa05219 | 0.19969103 |
| 130 | Purine metabolism_Homo sapiens_hsa00230 | 0.18964742 |
| 131 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.18590054 |
| 132 | Tuberculosis_Homo sapiens_hsa05152 | 0.18541922 |
| 133 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.18465832 |
| 134 | Legionellosis_Homo sapiens_hsa05134 | 0.18455828 |
| 135 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.18270486 |
| 136 | Colorectal cancer_Homo sapiens_hsa05210 | 0.17580498 |
| 137 | Pathways in cancer_Homo sapiens_hsa05200 | 0.17402494 |
| 138 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.16514086 |
| 139 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.14555493 |
| 140 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.14256021 |
| 141 | Olfactory transduction_Homo sapiens_hsa04740 | 0.13592445 |
| 142 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.11658965 |
| 143 | Proteasome_Homo sapiens_hsa03050 | 0.09437098 |
| 144 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.09377710 |
| 145 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.08230958 |
| 146 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.08110444 |
| 147 | Insulin secretion_Homo sapiens_hsa04911 | 0.06638135 |
| 148 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.05717591 |
| 149 | Basal transcription factors_Homo sapiens_hsa03022 | 0.05584452 |

